Skip to main content

People in the News: Mar 12, 2010 (rev. 1)

Premium

David Botstein, Francis Collins, and Eric Lander have been named co-winners of the 2010 Albany Medical Center Prize in Medicine and Biomedical Research, which carries with it a purse of $500,000.

As leaders in the Human Genome Project, the three "undoubtedly will hold a special place in the history of science and medicine as primary initiators of a profound revolution in human development," James Barba, president and CEO of Albany Medical Center, said in a statement.

Collins was director of the National Human Genome Research Institute during the Human Genome Project and is now director of the National Institutes of Health. Botstein is director of the Lewis-Sigler Institute for Integrative Genomics at Princeton University. Lander is president and director of the Broad Institute.


David U'Prichard has joined the board of directors of Ocimum Biosolutions, the firm said this week.

U'Prichard is president of Druid Consulting, and sits on the boards of Life Technologies, Oxagen, Cyclacel, and Silence Therapeutics. He is also a venture partner at Red Abbey Venture Partners.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.